vs
Astrana Health, Inc.（ASTH）与芝商所（CME）财务数据对比。点击上方公司名可切换其他公司
芝商所的季度营收约是Astrana Health, Inc.的2.0倍（$1.9B vs $950.5M），Astrana Health, Inc.净利率更高（0.7% vs 0.1%，领先0.6%），Astrana Health, Inc.同比增速更快（42.9% vs 14.5%），过去两年Astrana Health, Inc.的营收复合增速更高（53.3% vs 10.8%）
Astrana Health是一家总部位于美国的价值导向型医疗服务提供商，主要服务全美符合联邦医保资格的老年群体，提供上门初级护理、慢性病管理及护理协调服务，致力于提升患者健康水平、降低不必要的医疗支出。
芝商所是总部位于美国伊利诺伊州芝加哥的金融服务企业，为全球规模最大的金融衍生品交易所运营商，旗下拥有芝加哥商品交易所、芝加哥期货交易所、纽约商业交易所、纽约商品交易所等交易平台，覆盖农产品、货币、能源等品类交易，同时持有标普道琼斯指数27%的股权。
ASTH vs CME — 直观对比
营收规模更大
CME
是对方的2.0倍
$950.5M
营收增速更快
ASTH
高出28.4%
14.5%
净利率更高
ASTH
高出0.6%
0.1%
两年增速更快
ASTH
近两年复合增速
10.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $950.5M | $1.9B |
| 净利润 | $6.6M | $1.2M |
| 毛利率 | — | — |
| 营业利润率 | 1.9% | 0.1% |
| 净利率 | 0.7% | 0.1% |
| 营收同比 | 42.9% | 14.5% |
| 净利润同比 | 184.4% | 20.7% |
| 每股收益（稀释后） | $0.12 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ASTHCME
| Q1 26 | — | $1.9B | ||
| Q4 25 | $950.5M | $1.6B | ||
| Q3 25 | $956.0M | $1.5B | ||
| Q2 25 | $654.8M | $1.7B | ||
| Q1 25 | $620.4M | $1.6B | ||
| Q4 24 | $665.2M | $1.5B | ||
| Q3 24 | $478.7M | $1.6B | ||
| Q2 24 | $486.3M | $1.5B |
净利润ASTHCME
| Q1 26 | — | $1.2M | ||
| Q4 25 | $6.6M | $1.2B | ||
| Q3 25 | $373.0K | $908.0M | ||
| Q2 25 | $9.4M | $1.0B | ||
| Q1 25 | $6.7M | $956.2M | ||
| Q4 24 | $-7.8M | $874.6M | ||
| Q3 24 | $16.1M | $912.8M | ||
| Q2 24 | $19.2M | $883.2M |
营业利润率ASTHCME
| Q1 26 | — | 0.1% | ||
| Q4 25 | 1.9% | 61.8% | ||
| Q3 25 | 2.0% | 63.3% | ||
| Q2 25 | 3.1% | 66.7% | ||
| Q1 25 | 3.3% | 67.5% | ||
| Q4 24 | 0.1% | 62.1% | ||
| Q3 24 | 5.9% | 64.6% | ||
| Q2 24 | 6.2% | 65.3% |
净利率ASTHCME
| Q1 26 | — | 0.1% | ||
| Q4 25 | 0.7% | 71.7% | ||
| Q3 25 | 0.0% | 59.1% | ||
| Q2 25 | 1.4% | 60.6% | ||
| Q1 25 | 1.1% | 58.2% | ||
| Q4 24 | -1.2% | 57.3% | ||
| Q3 24 | 3.4% | 57.6% | ||
| Q2 24 | 3.9% | 57.6% |
每股收益（稀释后）ASTHCME
| Q1 26 | — | — | ||
| Q4 25 | $0.12 | $3.24 | ||
| Q3 25 | $0.01 | $2.49 | ||
| Q2 25 | $0.19 | $2.81 | ||
| Q1 25 | $0.14 | $2.62 | ||
| Q4 24 | $-0.14 | $2.40 | ||
| Q3 24 | $0.33 | $2.50 | ||
| Q2 24 | $0.40 | $2.42 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $429.5M | $2.4B |
| 总债务越低越好 | — | $3.4B |
| 股东权益账面价值 | $779.3M | — |
| 总资产 | $2.2B | $202.0B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资ASTHCME
| Q1 26 | — | $2.4B | ||
| Q4 25 | $429.5M | $4.5B | ||
| Q3 25 | $463.4M | $2.6B | ||
| Q2 25 | $342.1M | $2.1B | ||
| Q1 25 | $260.9M | $1.5B | ||
| Q4 24 | $290.8M | $3.0B | ||
| Q3 24 | $350.3M | $2.4B | ||
| Q2 24 | $327.7M | $1.9B |
总债务ASTHCME
| Q1 26 | — | $3.4B | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益ASTHCME
| Q1 26 | — | — | ||
| Q4 25 | $779.3M | $28.7B | ||
| Q3 25 | $775.5M | $28.2B | ||
| Q2 25 | $765.5M | $27.7B | ||
| Q1 25 | $745.4M | $27.0B | ||
| Q4 24 | $712.7M | $26.5B | ||
| Q3 24 | $704.6M | $28.2B | ||
| Q2 24 | $678.9M | $27.6B |
总资产ASTHCME
| Q1 26 | — | $202.0B | ||
| Q4 25 | $2.2B | $198.4B | ||
| Q3 25 | $2.2B | $187.1B | ||
| Q2 25 | $1.4B | $179.9B | ||
| Q1 25 | $1.3B | $157.8B | ||
| Q4 24 | $1.4B | $137.4B | ||
| Q3 24 | $1.3B | $137.8B | ||
| Q2 24 | $1.3B | $123.4B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-2.9M | — |
| 自由现金流经营现金流 - 资本支出 | $-6.0M | — |
| 自由现金流率自由现金流/营收 | -0.6% | — |
| 资本支出强度资本支出/营收 | 0.3% | — |
| 现金转化率经营现金流/净利润 | -0.44× | — |
| 过去12个月自由现金流最近4个季度 | $104.5M | — |
8季度趋势，按日历期对齐
经营现金流ASTHCME
| Q1 26 | — | — | ||
| Q4 25 | $-2.9M | $1.1B | ||
| Q3 25 | $10.0M | $968.1M | ||
| Q2 25 | $90.9M | $1.1B | ||
| Q1 25 | $16.6M | $1.1B | ||
| Q4 24 | $-10.9M | $1.0B | ||
| Q3 24 | $34.0M | $1.0B | ||
| Q2 24 | $23.2M | $776.9M |
自由现金流ASTHCME
| Q1 26 | — | — | ||
| Q4 25 | $-6.0M | $1.1B | ||
| Q3 25 | $7.4M | $949.7M | ||
| Q2 25 | $89.5M | $1.0B | ||
| Q1 25 | $13.6M | $1.1B | ||
| Q4 24 | $-13.5M | $991.7M | ||
| Q3 24 | $31.7M | $973.2M | ||
| Q2 24 | $20.4M | $758.7M |
自由现金流率ASTHCME
| Q1 26 | — | — | ||
| Q4 25 | -0.6% | 66.8% | ||
| Q3 25 | 0.8% | 61.8% | ||
| Q2 25 | 13.7% | 61.5% | ||
| Q1 25 | 2.2% | 67.1% | ||
| Q4 24 | -2.0% | 65.0% | ||
| Q3 24 | 6.6% | 61.4% | ||
| Q2 24 | 4.2% | 49.5% |
资本支出强度ASTHCME
| Q1 26 | — | — | ||
| Q4 25 | 0.3% | 2.0% | ||
| Q3 25 | 0.3% | 1.2% | ||
| Q2 25 | 0.2% | 1.1% | ||
| Q1 25 | 0.5% | 0.9% | ||
| Q4 24 | 0.4% | 1.7% | ||
| Q3 24 | 0.5% | 1.9% | ||
| Q2 24 | 0.6% | 1.2% |
现金转化率ASTHCME
| Q1 26 | — | — | ||
| Q4 25 | -0.44× | 0.96× | ||
| Q3 25 | 26.69× | 1.07× | ||
| Q2 25 | 9.65× | 1.03× | ||
| Q1 25 | 2.48× | 1.17× | ||
| Q4 24 | — | 1.16× | ||
| Q3 24 | 2.11× | 1.10× | ||
| Q2 24 | 1.21× | 0.88× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASTH
| Medicare | $542.4M | 57% |
| Commercial | $99.1M | 10% |
| Care Delivery | $92.1M | 10% |
| Care Enablement | $78.9M | 8% |
| Other Third Parties | $58.0M | 6% |
| Health Care Patient Service | $39.8M | 4% |
| Health Care Other | $25.5M | 3% |
| Other | $12.1M | 1% |
| Management Service | $10.3M | 1% |
CME
暂无分部数据
